However, in the United States, the incidence of prostate cancer increased sharply from 1975 to 1991 with the peak in the early 1990s due to the widespread use of prostate-specific antigen (PSA) screening through which many men with asymptomatic prostate cancer were detected (1). Here, KLK3 is linked to prostate cancer.